BACKGROUND: The pancreatic cancer-associated fibroblasts (pCAFs) are among the most active components of the pancreatic ductal adenocarcinoma (PDAC). The pCAFs being of mesenchymal stem/stromal cell origin, interact directly with tumor stromal elements, modulate tumor development, and are involved in the formation of pre-metastatic niches that result in unsatisfactory PDAC treatment outcomes. This study aimed to develop an innovative approach for the treatment of desmoplastic pancreatic carcinoma via intracellularly targeted exosomes derived from pCAFs and from mesenchymal stem cells (MSCs) transduced with the suicide gene - yeast cytosine deaminase::uracil phosphoribosyl transferase (yCD::UPRT). METHODS: pCAFs were isolated from four PDAC tumor specimens and MSCs from various tissues. Their transduction with yCD::UPRT gene produce homogenous gene transduced cell populations capable of secreting suicide gene exosomes. Both gene- transduced and naive cells and their exosomes underwent characterization by biophysical, biochemical, microscopic, and LC-MS/MS proteomic methods. Tumor cell-killing functionality was assessed using three pancreatic cancer cell lines. The killing efficacy of combined suicide gene exosomes of MSCs and pCAFs was measured in a mixture of pCAFs and MIA PaCa-2 cells as a simulated desmoplastic pancreatic tumor in vitro. RESULTS: MSCs and pCAFs suicide gene exosomes act as cancer cell-targeted drugs, effectively killing pancreatic carcinoma cells. Exosomes intracellular convert the non-toxic prodrug 5-fluorocytosine into cytotoxic 5-fluorouracil and its metabolites in a dose-dependent manner. In experiments simulating the desmoplastic microenvironment of PDAC, we have found that the suicide gene exosomes from both cells conjugated with prodrug effectively target and inhibit the growth of simulated PDAC. CONCLUSION: Exosomes containing the yCD::UPRT gene from pCAFs and MSCs function as "Trojan horse" therapies, efficiently and dose-dependently eliminating pancreatic cancer cells. PDAC environment-targeted yCD::UPRT-gene exosomes from MSCs and pCAFs show promise for a novel PDAC treatment.

Cancer Research Institute Biomedical Research Center Slovak Academy of Sciences Bratislava Slovakia

Central European Institute of Technology Masaryk University Brno Czech Republic

Department of Oncology Faculty of Medicine Comenius University National Cancer Institute Bratislava Slovakia

Department of Pathology National Cancer Institute Bratislava Bratislava Slovakia

Department of Stem Cell Preparation St Elisabeth Cancer Institute Bratislava Slovakia

Department of Surgical Oncology National Cancer Institute in Bratislava Bratislava Slovakia

Zobrazit více v PubMed

Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008–20. 10.1016/S0140-6736(20)30974-0. PubMed DOI

Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021;184:6119–37. 10.1016/j.cell.2021.11.017. PubMed DOI PMC

Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010;9:129. http://www.molecular-cancer.com/content/9/1/129. PubMed DOI PMC

Cumming J, Maneshi P, Dongre M, Alsaed T, Dehghan-Nayeri MJ, Ling A, et al. Dissecting FAP + Cell diversity in pancreatic cancer uncovers an Interferon-Response subtype of cancer-Associated fibroblasts with Tumor-Restraining properties. Cancer Res. 2025;85(13):2388–411. 10.1158/0008-5472.CAN-23-3252. PubMed DOI PMC

Götze J, Meißner K, Pereira-Veiga T, Belloum Y, Schneegans S, Kropidlowski J, et al. Identification and characterization of tumor and stromal derived liquid biopsy analytes in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2025;44(1):14. 10.1186/s13046-024-03262-x. PubMed DOI PMC

Liang C, Shi S, Meng Q, Liang D, Ji S, Zhang B, et al. Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going. Exp Mol Med. 2017;49(12):e406. 10.1038/emm.2017.255. PubMed DOI PMC

Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735–47. 10.1016/j.ccr.2014.04.021. PubMed DOI PMC

Li J, Wang J, Chen Z. Emerging role of exosomes in cancer therapy: progress and challenges. Mol Cancer. 2025;24(1):13. 10.1186/s12943-024-02215-4. PubMed DOI PMC

Li Q, He G, Yu Y, Li X, Peng X, Yang L. Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies. Stem Cell Res Ther. 2024;15(1):449. 10.1186/s13287-024-04061-z. PubMed DOI PMC

Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17. 10.1038/s41392-023-01704-0. PubMed DOI PMC

Altaner C. Prodrug cancer gene therapy. Cancer Lett. 2008;270(2):191–201. 10.1016/j.canlet.2008.04.023. PubMed DOI

Altanerova U, Jakubechova J, Benejova K, Priscakova P, Pesta M, Pitule P, et al. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes. Int J Cancer. 2019;144(4):897–908. 10.1002/ijc.31792. PubMed DOI

Altanerova U, Jakubechova J, Benejova K, Priscakova P, Repiska V, Babelova A, et al. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes. Int J Cancer. 2021;148(1):128–39. 10.1002/ijc.33188. PubMed DOI

Tibensky M, Jakubechova J, Altanerova U, Pastorakova A, Rychly B, Baciak L, et al. Gene-directed enzyme/prodrug therapy of rat brain tumor mediated by human mesenchymal stem cell suicide gene extracellular vesicles in vitro and in vivo. Cancers (Basel). 2022;14(3):735. 10.3390/cancers14030735. PubMed DOI PMC

Buocikova V, Altanerova U, Soltysova A, Andrezal M, Vanova D, Jakubechova J, et al. Placental mesenchymal stem cells: a promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma. Biomed Pharmacother. 2025;190:118428. 10.1016/j.biopha.2025.118428. PubMed DOI

Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007;67(13):6304–13. 10.1158/0008-5472.CAN-06-4024. PubMed DOI

Stanko P, Kaiserova K, Altanerova V, Altaner C. Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(3):373–7. 10.5507/bp.2013.078. PubMed DOI

Altaner C, Altanerova U. Mesenchymal stem cell exosome-mediated prodrug gene therapy for cancer. Methods Mol Biol. 2019;1895:75–85. 10.1007/978-1-4939-8922-5_6. PubMed DOI

Stejskal K, Potěšil D, Zdráhal Z. Suppression of peptide sample losses in autosampler vials. J Proteome Res. 2013;12(6):3057–62. 10.1021/pr400183v. PubMed DOI

Wiśniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359–62. 10.1038/nmeth.1322. PubMed DOI

Kearney JF, Trembath HE, Chan PS, Morrison AB, Xu Y, Luan CF, et al. Myofibroblastic cancer-associated fibroblast subtype heterogeneity in pancreatic cancer. J Surg Oncol. 2024;129(5):860–8. 10.1002/jso.27582. PubMed DOI PMC

Li Y, Liu Y, Yang X, Yang B, Cheng J, Chen J, et al. Effects of mesenchymal stem cells from different sources on the biological functions of multiple myeloma cells. Stem Cell Res Ther. 2025;16(1):89. 10.1186/s13287-025-04222-8. PubMed DOI PMC

Sinanan AC, Hunt NP, Lewis MP. Human adult craniofacial muscle-derived cells: neural-cell adhesion-molecule (NCAM; CD56)-expressing cells appear to contain multipotential stem cells. Biotechnol Appl Biochem. 2004;40(Pt 1):25–34. PubMed DOI

Fecskeova LK, Matejova J, Slovinska L, Bzdilova J, Kozovská Z, Harvanova D. Chorion tissue- and plasma-derived extracellular vesicles exhibit superior anti-inflammatory and chondroprotective effects. Stem Cell Res Ther. 2025;16(1):423. 10.1186/s13287-025-04542-9. PubMed DOI PMC

Komaki M, Numata Y, Morioka C, Honda I, Tooi M, Yokoyama N, et al. Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis. Stem Cell Res Ther. 2017;8(1):219. 10.1186/s13287-017-0660-9. PubMed DOI PMC

Chen W, Peng W, Wang R, Bai S, Cao M, Xiong S, et al. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells. Cell Death Dis. 2024;15(1):102. 10.1038/s41419-024-06482-3. PubMed DOI PMC

Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329–35. 10.1038/nature15756. PubMed DOI PMC

Creeden JF, Sevier J, Zhang JT, Lapitsky Y, Brunicardi FC, Jin G, et al. Smart exosomes enhance PDAC targeted therapy. J Control Release. 2024. 10.1016/j.jconrel.2024.02.037. PubMed DOI PMC

Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 2018;20(3):332–43. 10.1038/s41556-018-0040-4. PubMed DOI PMC

Zhang Q, Higginbotham JN, Jeppesen DK, Yang YP, Li W, McKinley ET, et al. Transfer of functional cargo in exomeres. Cell Rep. 2019;27(3):940-954.e6. 10.1016/j.celrep.2019.01.009. PubMed DOI PMC

Vanova D, Andrezal M, Jakubechova J, Altanerova U, Altaner C. Participation of suicide gene extracellular vesicles in metastasis prevention. Neoplasma. 2024;71(2):117–22. 10.4149/neo_2024_240208N59. PubMed DOI

Klimova D, Jakubechova J, Altanerova U, Nicodemou A, Styk J, Szemes T, et al. Extracellular vesicles derived from dental mesenchymal stem/stromal cells with gemcitabine as a cargo have an inhibitory effect on the growth of pancreatic carcinoma cell lines in vitro. Mol Cell Probes. 2023;67:101894. 10.1016/j.mcp.2023.101894. PubMed DOI

Durinikova E, Plava J, Tyciakova S, Skvara P, Vojs Stanova A, Kozovska Z, et al. Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme/prodrug treatment. Cancer Gene Ther. 2018;25(11–12):285–99. 10.1038/s41417-018-0030-5. PubMed DOI

Espona-Fiedler M, Patthey C, Lindblad S, Sarró I, Öhlund D. Overcoming therapy resistance in pancreatic cancer: new insights and future directions. Biochem Pharmacol. 2024;229:116492. 10.1016/j.bcp.2024.116492. PubMed DOI

Setua S, Shabir S, Shaji P, Bulnes AM, Dhasmana A, Holla S, et al. Exosomes derived from tumor adjacent fibroblasts efficiently target pancreatic tumors. Acta Pharm Sin B. 2024;14(7):3009–26. 10.1016/j.apsb.2024.04.003. PubMed DOI PMC

Quan J, Liu Q, Li P, Yang Z, Zhang Y, Zhao F, et al. Mesenchymal stem cell exosome therapy: current research status in the treatment of neurodegenerative diseases and the possibility of reversing normal brain aging. Stem Cell Res Ther. 2025;16(1):76. 10.1186/s13287-025-04160-5. PubMed DOI PMC

Luan X, Wang X, Bian G, Li X, Gao Z, Liu Z, et al. Exosome applications for the diagnosis and treatment of pancreatic ductal adenocarcinoma: an update (Review). Oncol Rep. 2025;53(1):13. 10.3892/or.2024.8846. PubMed DOI PMC